Integra LifeSciences Reports Third-Quarter 2026 Revenue of $411.18 Million
Net income was $14.85 million and diluted EPS was $0.19, compared with a $5.4 million net loss and a $0.07 per-share loss a year earlier. Revenue was $402.06 million in the prior-year quarter.